Nalaganje...

SGLT2i: beyond the glucose-lowering effect

Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitus (T2DM)....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiovasc Diabetol
Main Authors: Ni, Lihua, Yuan, Cheng, Chen, Guopeng, Zhang, Changjiang, Wu, Xiaoyan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320582/
https://ncbi.nlm.nih.gov/pubmed/32590982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01071-y
Oznake: Označite
Brez oznak, prvi označite!